Teikoku has a strong history of collaborating with organizations to successfully bring new products to market.

Partnering with Teikoku offers pharmaceutical companies greater opportunities to diversify their product portfolio and extend patent protections, both of which are important strategies for business growth. In addition, our solutions improve the safety profile and compliance of drugs. Finally, our team of dedicated scientists and researchers use their extensive drug development expertise to ensure new products are developed quickly and with the necessary focus to achieve FDA approval.

In all, we provide the flexibility, experience and commitment that help to accelerate the drug development process. Our history of past product successes and a continued dedication to innovation allow us to work with our clients to bring these innovative solutions to market.

Some of our partners are:

• Endo Pharmaceuticals
• Grünenthal
• Mundipharma
• SK Chemicals
• Eisai
• Novartis
• Bayer
• IBSA
• King Pharmaceuticals  
• Leo Pharma
• Torii Pharmaceutical Co, LTD.
• Wyeth
• Pfizer
• Shiseido
• BDF Beiersdorf
• Lancôme Paris
• Lion
• Takeda

To find out more, please contact:
Francisco Bejar
Associate Director, Business Development
Phone: 408-501-1804
Fax: 408-501-1904
fbejar@teikokuusa.com